Key result
Microinjection of the non-specific glutamate receptor antagonist kynurenic acid into the A5 region decreased the intensity of both tachypnoea and tachycardia induced by dlPAG stimulation.
Why the study?
To characterize the role of glutamate within the functional interaction between the midbrain dlPAG and the pontine A5 region during evoked cardiorespiratory responses.
Glutamatergic neurotransmission in the pontine A5 region plays a key neuromodulatory role in the cardiorespiratory defense response evoked by the midbrain dlPAG.
Answers are grounded in this paper and cite their sources.
Animal data suggest A5 glutamatergic targets for defense response modulation; leaves open human translation.
Stimulation of the dorsolateral periaqueductal grey matter (dlPAG) in rats evokes an active defensive behaviour together with a cardiorespiratory response characterised by tachypnoea, tachycardia and hypertension. The dlPAG neurons involved in these responses are excitatory, presumably glutamatergic, due to the presence of vesicular glutamate transporter VGLUT2 within their axon terminals. Previously, our group described a functional interaction between dlPAG and the pontine A5 region. Accordingly, in the present work, in order to characterize the role of glutamate within this interaction, experiments were carried out in spontaneously breathing anaesthetized rats (sodium pentobarbitone 60 mg/kg i.p., suplemented with 20 mg/kg i.p.). The cardiorespiratory response evoked by electrical stimulation of the dlPAG (1ms pulses, 20-50 mA, given at 100 Hz, during 5s) was analysed before and after the microinjection, within the A5 region, of either kynurenic acid (non-specific glutamate receptor antagonist; 5-10 nmol), DAP-5 (NMDA antagonist; 1 pmol), CNQX (non-NMDA antagonist; 1 pmol) or MCPG (metabotropic antagonist; 0,1 nmol). Kynurenic acid decreased the intensity of both the tachypnoea (p<0,001) and tachycardia (p<0,001) induced by dl-PAG stimulation. Blockade of no-NMDA receptors reduced the increase of respiratory frequency, heart rate and pressor response to dl-PAG stimulation (p<0,01, p<0,001, p<0,05 respectively). Blockade of either NMDA or metabotropic receptors reduced the dlPAG-evoked tachycardia and pressor response (p<0,01; p<0,05 respectively). These results suggest a neuromodulatory role for A5 region via glutamate neurotransmission of the dlPAG-evoked cardiorespiratory response, confirming the role of the ventrolateral pons in the neuronal circuits involved in respiratory and heart rate control.
No takes yet. Share an insight, caveat, or question.
González-García et al. (2022) studied Cardiorespiratory response evoked by dlPAG stimulation (n=50). Glutamate receptor antagonists (kynurenic acid, DAP-5, CNQX, MCPG) vs. PBS microinjection was evaluated on Intensity of tachypnoea and tachycardia induced by dlPAG stimulation (p=<0.001). Microinjection of the non-specific glutamate receptor antagonist kynurenic acid into the A5 region decreased the intensity of both tachypnoea and tachycardia induced by dlPAG stimulation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: